{"id":"NCT00683618","sponsor":"AstraZeneca","briefTitle":"Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia","officialTitle":"A Randomised, Double-blind Trial to Compare the Efficacy of Rosuvastatin 5 and 10 mg to Atorvastatin 10 mg in the Treatment of High Risk Patients With Hypercholesterolemia Followed by an Open Label Treatment Period With Rosuvastatin Up-titrated to the Maximum Dose of 20 mg for Those Patients Who do Not Achieve Goal","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-05","primaryCompletion":"2009-07","completion":"2009-07","firstPosted":"2008-05-23","resultsPosted":"2012-03-12","lastUpdate":"2012-03-21"},"enrollment":934,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Rosuvastatin","otherNames":["Crestor"]},{"type":"DRUG","name":"Atorvastatin","otherNames":["Lipitor"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is to compare the efficacy, safety and tolerability of Rosuvastatin with Atorvastatin by assessing the change of LDL-C in patients with hypercholesterolemia and history of coronary heart disease (CHD) or risk equivalent, or a 10 year CHD risk of no less than 10%, following 6-week treatment and a possible 6 week extension treatment.","primaryOutcome":{"measure":"Percentage Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) Concentration After 6 Weeks of Treatment Comparing Rosuvastatin 5mg With Atorvastatin 10mg","timeFrame":"baseline, 6 weeks","effectByArm":[{"arm":"Rosuvastatin 5mg","deltaMin":-41.7,"sd":2.62},{"arm":"Atorvastatin 10mg","deltaMin":-38.67,"sd":2.64}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":6,"countries":["China"]},"refs":{"pmids":["28836458"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":145},"commonTop":["Blood Creatine Phosphokinase Increased","Alanine Aminotransferase","Myalgia"]}}